PTK2B and colorectal cancer: The only available data about the role of LDH levels and an antiangiogenic treatment are those deriving from the recently published trials investigating PTK/ZK (vatalanib), an oral inhibitor of VEGF receptors, in first- and second-line therapy of advanced colorectal cancer.